Skip to search formSkip to main contentSkip to account menu

MCO chemical

Known as: (6R,7R)-7-((2R)-2-hydroxy-2-phenylacetamido)-3-(pyrid-2-yl-N-oxide)thiomethylceph-3-em 4-carboxylic acid, (6R-(6 alpha,7 beta(R)))-7-((hydroxyphenylacetyl)amino)-8-oxo-3-((2-pyridinylthio) methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2- carboxylic acid monooxide, MCO 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cephalosporins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
The two oxidized forms of the trinuclear Cu cluster in the multicopper oxidases and mechanism for the decay of the native intermediate
Multicopper oxidases (MCOs) catalyze the 4e− reduction of O2 to H2O. The reaction of the fully reduced enzyme with O2 generates… 
Highly Cited
2006
Highly Cited
2006
Transition metal-peptide binding studied by metal-catalyzed oxidation reactions and mass spectrometry.
We have identified conditions that allow metal-catalyzed oxidation (MCO) reactions and mass spectrometry (MS) to correctly… 
2006
2006
Using metal-catalyzed oxidation reactions and mass spectrometry to identify amino acid residues within 10 Å of the metal in Cu-binding proteins
Highly Cited
2005
Highly Cited
2005
Methionine regulates copper/hydrogen peroxide oxidation products of Aβ
Metal‐catalysed oxidation (MCO) may play a causative role in the pathogenesis of Alzheimer's disease (AD). Amyloid β peptide (A… 
Review
2005
Review
2005
MODELING OF HOUSEHOLD MOTORCYCLE OWNERSHIP BEHAVIOUR IN HANOI CITY
The rapid increase of motorcycle ownership associated with inadequate public transport has largely contributed to increased… 
Highly Cited
2003
Highly Cited
2003
Development of a methodology based on metal-catalyzed oxidation reactions and mass spectrometry to determine the metal binding sites in copper metalloproteins.
Efforts have been made to develop a method that uses metal-catalyzed oxidation (MCO) reactions and mass spectrometry (MS) to… 
Review
2001
Review
2001
Professional advice and readiness to change behavioral risk factors among members of a managed care organization.
OBJECTIVE To ascertain factors related to readiness to change behavioral risk factors in members of a managed care organization… 
Review
2000
Review
2000
Specific clinical competencies for managing care: views of residency directors and managed care medical directors.
CONTEXT Although medical educators recognize the need to prepare physicians to work effectively in managed care environments… 
1991
1991
Characterization of a sulfotransferase responsible for the 4-O-sulfation of terminal beta-N-acetyl-D-galactosamine on asparagine-linked oligosaccharides of glycoprotein hormones.
1985
1985
The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model.
The symptomatic effect of cimetidine was examined in 27 patients with non-ulcer dyspepsia (NUD) by means of a multi-cross-over… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)